Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Cutting Edge: Cyclic Polypeptide and Aminoglycoside Antibiotics Trigger IL-1β Secretion by Activating the NLRP3 Inflammasome

Ramanjaneyulu Allam, Murthy Narayana Darisipudi, Khader Valli Rupanagudi, Julia Lichtnekert, Jurg Tschopp and Hans-Joachim Anders
J Immunol March 1, 2011, 186 (5) 2714-2718; DOI: https://doi.org/10.4049/jimmunol.1002657
Ramanjaneyulu Allam
*Medizinische Poliklinik, Universität München, Munich, Germany; and
†Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Murthy Narayana Darisipudi
*Medizinische Poliklinik, Universität München, Munich, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khader Valli Rupanagudi
*Medizinische Poliklinik, Universität München, Munich, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Lichtnekert
*Medizinische Poliklinik, Universität München, Munich, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jurg Tschopp
†Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Joachim Anders
*Medizinische Poliklinik, Universität München, Munich, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Polymyxin B, tyrothricin, gramicidin, and neomycin trigger IL-1β secretion. A, Murine BMDCs were primed with LPS and exposed to members of five different classes of antibiotics at a concentration of 50 μg/ml, and IL-1β secretion was measured in supernatants after 6 h of stimulation. ATP was used as a positive control. Note that only polymyxin B, tyrothricin, gramicidin, and neomycin induced IL-1β secretion. B, LPS primed BMDCs from TNFR1/2 and IL-1R1–deficient mice were exposed to 50 μg/ml of polymyxin B, tyrothricin, gramicidin, and neomycin. IL-1β secretion was measured in supernatants after 6 h of stimulation. Data are expressed as the mean ± SD from three independent experiments, all performed in triplicates.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    IL-1β secretion triggered by polymyxin B, tyrothricin, neomycin, and gramicidin requires all components of the NLRP3 inflammasome. A, Wild-type and NLRP3-deficient mice derived BMDCs were primed with LPS and exposed 50 μg/ml of polymyxin B, tyrothricin, gramicidin, and neomycin. IL-1β secretion was measured in supernatants after 6 h of stimulation. ATP was used as a positive control. B, Immunoblot analysis of mature IL-1β (p17) and caspase-1 cleavage product (p10) in wild-type and NLRP3-deficient BMDCs stimulated with antibiotics. C, IL-1β ELISA for wild-type and ASC-deficient BMDCs stimulated with antibiotics. Note that IL-1β secretion was dependent on the presence of NLRP3 and ASC for all drugs. D, Wild-type BMDCs were stimulated with antibiotics in the presence or absence of the caspase inhibitor Z-VAD-FMK. IL-1β secretion was measured in supernatants after 6 h of stimulation. Data are expressed as the mean ± SD from three independent experiments all performed in triplicates.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Polymyxin B, tyrothricin, gramicidin, and neomycin activate NLRP3 through different ways. A, LPS-primed wild type BMDCs were stimulated with antibiotics in serum-free buffer with or without 75 mM KCl and NaCl. IL-1β secretion was measured in supernatants after 6 h (B). Wild-type and P2X7-deficient BMDCs were primed with LPS and exposed to antibiotic. IL-1β secretion was measured in supernatants after 6 h of stimulation. ATP was used as control. C and D, LPS-primed wild type BMDCs were treated with cytochalasin D, N-acetyl cysteine (NAC), and CA-07-Me for 30 min. Pretreated cells were stimulated with antibiotics. IL-1β secretion was measured in supernatants after 6 h of stimulation. Data are expressed as the mean ± SD from three independent experiments all performed in triplicate.

Additional Files

  • Figures
  • Data Supplement

    Files in this Data Supplement:

    • Supplemental Figures 1-2 (PDF, 156 Kb) - Description:
      Figure 1. Antibiotics-induced IL-1 β production depends on LPS priming
      Figure 2. Antibiotcs induced IL-1β secretion other immune cells and neutrophil influx
PreviousNext
Back to top

In this issue

The Journal of Immunology: 186 (5)
The Journal of Immunology
Vol. 186, Issue 5
1 Mar 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cutting Edge: Cyclic Polypeptide and Aminoglycoside Antibiotics Trigger IL-1β Secretion by Activating the NLRP3 Inflammasome
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cutting Edge: Cyclic Polypeptide and Aminoglycoside Antibiotics Trigger IL-1β Secretion by Activating the NLRP3 Inflammasome
Ramanjaneyulu Allam, Murthy Narayana Darisipudi, Khader Valli Rupanagudi, Julia Lichtnekert, Jurg Tschopp, Hans-Joachim Anders
The Journal of Immunology March 1, 2011, 186 (5) 2714-2718; DOI: 10.4049/jimmunol.1002657

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cutting Edge: Cyclic Polypeptide and Aminoglycoside Antibiotics Trigger IL-1β Secretion by Activating the NLRP3 Inflammasome
Ramanjaneyulu Allam, Murthy Narayana Darisipudi, Khader Valli Rupanagudi, Julia Lichtnekert, Jurg Tschopp, Hans-Joachim Anders
The Journal of Immunology March 1, 2011, 186 (5) 2714-2718; DOI: 10.4049/jimmunol.1002657
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved
  • Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the Human Tonsil
  • Cutting Edge: Enhanced Antitumor Immunity in ST8Sia6 Knockout Mice
Show more CUTTING EDGE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606